SCHEMBL2491268

SCHEMBL2491268

CCCCCCCCCCCCC(O)COC(C)=O.[NaH]

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
USP2 O75604 3/20 0.54
CYP3A4 P08684 2/20 0.54
MAPT P10636 2/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
HPGD P15428 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
TP53 P04637 1/20 0.54
MAPK1 P28482 1/20 0.54
GPR84 Q9NQS5 8/20 0.52
FFAR1 O14842 2/20 0.50
FFAR4 Q5NUL3 1/20 0.50
KDM4E B2RXH2 1/20 0.49
DUSP3 P51452 1/20 0.49
LMNA P02545 1/20 0.49
NFKB1 P19838 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2492346 1.00 ALDH1A1 (0.54) ALDH1A1USP2CYP3A4MAPTMEN1
SCHEMBL2492598 1.00 ALDH1A1 (0.54) ALDH1A1USP2CYP3A4MAPTMEN1
SCHEMBL2489463 1.00 ALDH1A1 (0.54) ALDH1A1USP2CYP3A4MAPTMEN1
SCHEMBL2492324 1.00 ALDH1A1 (0.54) ALDH1A1USP2CYP3A4MAPTMEN1
SCHEMBL1785352 1.00 ALDH1A1 (0.54) ALDH1A1USP2CYP3A4MAPTMEN1
SCHEMBL9329637 0.98 ALDH1A1 (0.55) ALDH1A1USP2CYP3A4MAPTMEN1
SCHEMBL10847415 0.98 ALDH1A1 (0.55) ALDH1A1USP2CYP3A4MAPTMEN1
SCHEMBL10007317 0.98 ALDH1A1 (0.55) ALDH1A1USP2CYP3A4MAPTMEN1
SCHEMBL11506586 0.98 ALDH1A1 (0.55) ALDH1A1USP2CYP3A4MAPTMEN1
SCHEMBL10849155 0.98 ALDH1A1 (0.55) ALDH1A1USP2CYP3A4MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3006547-B1 FRAGRANCE-CONTAINING CAPSULE AND COSMETIC IN WHICH SAID CAPSULES ARE BLENDED SHISEIDO CO LTD (JP) 2019-10-30 EP disclosed
US-20160106637-A1 FRAGRANCE-CONTAINING CAPSULE AND COSMETIC IN WHICH SAID CAPSULES ARE BLENDED SHISEIDO COMPANY, LTD. (JP) 2016-04-21 US disclosed
EP-3006547-A1 FRAGRANCE-CONTAINING CAPSULE AND COSMETIC IN WHICH SAID CAPSULES ARE BLENDED Shiseido Company Ltd. (JP) 2016-04-13 EP disclosed
US-8668923-B2 Filmy compositions P & PF CO., LTD. (JP) 2014-03-11 US disclosed
EP-1887030-B1 FILMY COMPOSITIONS P & PF CO LTD (JP) 2011-10-26 EP disclosed
US-20100166868-A1 Filmy Compositions P & PF CO., LTD. (JP) 2010-07-01 US disclosed
EP-1887030-A1 FILMY COMPOSITIONS P & PF Co., Ltd. (JP) 2008-02-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100166868-A1 Filmy Compositions DSG1, SMURF1, SMURF2 ALDH1A1 4545/4885USP2 1733/4885CYP3A4 4214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.